IMUNON
Lawrenceville, New Jersey, United States · Biotechnology, Healthcare
IMUNON is a clinical-stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body’s natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. IMUNON is developing its non-viral DNA technology across its modalities. The first modality
Key facts
- Headquarters
- Lawrenceville, New Jersey, United States
- Employees
- 24
- Industries
- Biotechnology, Healthcare
- Status
- Public (IMNN)
- Website
- imunon.com
- Company page
Recent activity at IMUNON
Dates are the day the event happened, taken from the announcement or SEC filing, unless a row says otherwise.
IMUNON funding history
| Date | Round | Amount |
|---|---|---|
| May 2025 | Seed | $3.3M |
| Aug 2024 | Venture | $10.0M |
| Jun 2015 | Venture | $5.1M |
Leadership
- Johan Lindborg, BD Consultant
- Michael Tardugno, Chairman
- Douglas V. Faller, Chief Medical Officer
- Stacy Lindborg, President
Verified email and direct lines for IMUNON’s decision-makers are on Fundz. See plans or book a 15-minute walkthrough.
Employee benefit plans
IMUNON files 2 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Companies similar to IMUNON
- Tempest Therapeutics · Biotechnology, Healthcare
- Northwest Biotherapeutics · Biotechnology, Healthcare
- TuHURA Biosciences · Biotechnology, Healthcare
- Ovid Therapeutics · Biotechnology, Healthcare
- Werewolf Therapeutics · Biotechnology, Healthcare
About IMUNON: questions and answers
What does IMUNON do?
IMUNON is a clinical-stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the body’s natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. IMUNON is developing its non-viral DNA technology across its modalities. The first modality
Where is IMUNON headquartered?
IMUNON is headquartered in Lawrenceville, New Jersey, United States.
How many employees does IMUNON have?
IMUNON has about 24 employees.
Has IMUNON raised funding?
Yes. Fundz has recorded 3 funding events for IMUNON. The most recent, Seed of $3.3M, was in May 2025.
Who leads IMUNON?
Stacy Lindborg is a President at IMUNON.
What is the latest news on IMUNON?
On May 27, 2025, IMUNON
Is IMUNON a public company?
Yes. IMUNON is publicly traded under the ticker IMNN.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy